AMH & the biological clock: when to consider freezing
The anti-Müllerian hormone (AMH) test has become very popular, often advertised as a “fertility test” or as the clock showing how much time you have left to have a baby. The reality is more subtle — and understanding it correctly prevents needless anxiety and wrong decisions.
AMH is a valuable tool, but it measures something very specific: the quantity, not the quality, of eggs. The real “biological clock” is still, above all, age.
What does AMH really measure?
AMH is produced by the small, growing follicles of the ovary. Its level in the blood reflects, approximately, the ovarian reserve — that is, the number of eggs remaining. As the years pass, eggs diminish and AMH falls.
It is crucial, however, to stress what AMH does not measure: it does not measure egg quality. A woman may have low AMH but good-quality eggs for her age, and vice versa.
Does AMH predict whether I will conceive naturally?
Not reliably. This is perhaps the most misunderstood point. In women with no known fertility problem, AMH does not reliably predict either the chance of natural conception or the time left to have a baby.
A low AMH in a young woman does not mean she is infertile; it simply means she has fewer eggs than the average for her age. This is why using AMH as a general population “fertility test” is discouraged — it causes more anxiety than useful information.
Why does age remain the main factor?
With age, not only the number but also the quality of eggs declines — that is, the proportion of eggs with chromosomal abnormalities rises. This leads to lower conception rates and higher miscarriage rates as a woman gets older.
AMH does not capture this fall in quality. This is why, in assessing fertility, the woman’s age remains the strongest and most reliable indicator — more important than the AMH value.
Where, then, is AMH useful?
AMH is very useful within a specific context. It helps the doctor predict how the ovaries will respond to ovarian stimulation during IVF or egg freezing, and to adjust the drug dose safely.
In counselling for egg freezing, AMH helps estimate, together with age, how many eggs it is realistic to collect. It is, in other words, a tool for planning treatment, not for predicting natural fertility.
When is it worth considering egg freezing?
Egg freezing can be a reasonable option for a woman who wants a child in the future but not yet, and wishes to reduce the impact of age. Because both the number and the quality of eggs are better at a younger age, the earlier freezing is done, the better the likely yield.
Generally, freezing before the age of 35 offers a better outlook. It is not, however, a guarantee: stored eggs increase the chances, they do not secure them. The decision needs realistic, individualized counselling.
What is the key message about AMH?
AMH is an indicator of egg quantity, useful for planning treatment — not a clock showing the deadline for having a child. A single value should neither reassure excessively nor frighten.
The right step, especially if you are considering egg freezing or are worried about your fertility, is a full assessment by a specialist, who will place AMH in its proper position alongside your age and your history.
Summary
AMH reflects the quantity, not the quality, of eggs, and does not reliably predict natural conception or the “deadline” for a baby; as a general fertility test it causes more anxiety than useful information. The woman’s age remains the strongest indicator. AMH’s real value is in planning ovarian stimulation and in counselling for egg freezing. When freezing is desired, it is best done at a younger age — ideally before 35 — but it increases the chances without guaranteeing them. Correct interpretation requires individualized counselling.
Sources: ESHRE, “Ovarian Stimulation for IVF/ICSI” (guideline, role of AMH in predicting response); ESHRE Task Force on Ethics and Law, opinion on planned oocyte cryopreservation (oocyte cryopreservation for age-related fertility loss).
⚕ Medically reviewed by Prof. Stratis Kolibianakis · Thessaloniki Medical Association Reg. No. 16340
ARTICLE 30 · GAMETE DONATION & LAW
